Applications of Venom Proteins as Potential Anticancer Agents.

Autor:	Ejaz S; Department of Biochemistry and Biotechnology, The Islamia University of Bahawalpur, Bahawalpur, Pakistan., Hashmi FB; Department of Biochemistry and Biotechnology, The Islamia University of Bahawalpur, Bahawalpur, Pakistan., Malik WN; Department of Biochemistry and Biotechnology, The Islamia University of Bahawalpur, Bahawalpur, Pakistan., Ashraf M; Department of Chemistry, The Islamia University of Bahawalpur, Bahawalpur, Pakistan., Nasim FU; Department of Chemistry, The Islamia University of Bahawalpur, Bahawalpur, Pakistan.; Department of Chemistry, Government Sadiq College Women University, Bahawalpur, Pakistan., Iqbal M; Department of Biochemistry and Biotechnology, The Islamia University of Bahawalpur, Bahawalpur, Pakistan.
Jazyk:	angličtina
Zdroj:	Protein and peptide letters [Protein Pept Lett] 2018; Vol. 25 (7), pp. 688-701.
DOI:	10.2174/0929866524666180614102104
Abstrakt:	Background: Venoms, the secretions of venomous animals, are conventionally thought to be the source of toxic substances though the views about venoms in the recent era have been changed. Venoms are the proven source of many biologically and pharmacologically important useful molecules. Bioactive components present in different venoms are mainly proteins and peptides either enzymatic or non-enzymatic which have tremendous therapeutic potential and are being used for the treatment of variety of diseases including cancer. Many venom proteins and peptides have been reported as potential anticancer agents. Conclusion: Venom proteins kill cancer cells through a variety of mechanisms which induce apoptosis and ultimately lead to cell death. Therefore, the understanding regarding sources and classification of venoms, biological role of venomous proteins, their anticancer potential and mechanisms to suppress/kill cancer cells needs to be addressed. The present review is an attempt to highlight the reported work and develop strategies to answer the key questions regarding the use of venomous proteins as therapeutic agents. (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu